Pepdox
Studies
Peptides
Calculator
Oral Semaglutide and Cardiovascular Outcomes. Reply. | Pepdox
Home
/
Search
/
PMID 40802953
Oral Semaglutide and Cardiovascular Outcomes. Reply.
The New England journal of medicine
2025
PMID: 40802953
View on PubMed
DOI: 10.1056/NEJMc2508958
Semaglutide
Authors
McGuire, Darren K; David, Jens-Peter; Inzucchi, Silvio E